Objective: This study aims to determine the effect of the inclusion complex formation of ibuprofen (IB) with β-cyclodextrin (β-CD) in improving water solubility and taste masking as well as to study the effect of the combined use of super disintegrants in IB-β-CD ODT (Orally disintegrating tablet). Methods: IB-β-CD inclusion complex was prepared by spray drying technique with a 1:1 molar ratio. ODTs were prepared by the direct compression method using various ratios of Ac-Di-Sol® and Kollidon® CL as super disintegrant. The inclusion complex was characterized using spectroscopy FT-IR (Fourier-transform infrared) and DSC (Differential Scanning Calorimetry). The physical properties and dissolution rate o...
Objective: This study aimed to mask the bitter taste of itopride HCl using the solid dispersion meth...
The present study was designed to evaluate the preparation and quality of ibuprofen and diphenhydram...
Objective: Glibenclamide belongs to the 2nd generation sulfonylurea group as an oral antidiabetic wi...
Objective: The aim of the present investigation was to design and evaluate orally disintegrating tab...
Objective: The study aimed to develop and evaluate an orally disintegrating tablet that contains pil...
Ibuprofen is a compound with low solubility but high permeability in water. One method to improve th...
Background: Glibenclamide is an oral antidiabetic drug which is practically insoluble in water. Form...
Ibuprofen is classified as a BCS class II because of its low solubility and high permeability. Inclu...
The objective of this work was to develop solid dosage forms using powders containing inclusion comp...
Objective: The study aimed to prepare and characterize inclusion complexes of tacrolimus with β-cycl...
The inclusion complex is one way to enhance active substance solubility, affecting medicine dissolut...
Orally disintegrating tablets (ODTs) are capable of turning quickly into a liquid dosage form in con...
NOTICE: this is the author’s version of a work that was accepted for publication in European Journal...
The inclusion complex is one way to enhance active substance solubility, affecting medicine dissolut...
Objective: The main aim is to design, optimize, and evaluate ibuprofen fast-dissolving tablets by em...
Objective: This study aimed to mask the bitter taste of itopride HCl using the solid dispersion meth...
The present study was designed to evaluate the preparation and quality of ibuprofen and diphenhydram...
Objective: Glibenclamide belongs to the 2nd generation sulfonylurea group as an oral antidiabetic wi...
Objective: The aim of the present investigation was to design and evaluate orally disintegrating tab...
Objective: The study aimed to develop and evaluate an orally disintegrating tablet that contains pil...
Ibuprofen is a compound with low solubility but high permeability in water. One method to improve th...
Background: Glibenclamide is an oral antidiabetic drug which is practically insoluble in water. Form...
Ibuprofen is classified as a BCS class II because of its low solubility and high permeability. Inclu...
The objective of this work was to develop solid dosage forms using powders containing inclusion comp...
Objective: The study aimed to prepare and characterize inclusion complexes of tacrolimus with β-cycl...
The inclusion complex is one way to enhance active substance solubility, affecting medicine dissolut...
Orally disintegrating tablets (ODTs) are capable of turning quickly into a liquid dosage form in con...
NOTICE: this is the author’s version of a work that was accepted for publication in European Journal...
The inclusion complex is one way to enhance active substance solubility, affecting medicine dissolut...
Objective: The main aim is to design, optimize, and evaluate ibuprofen fast-dissolving tablets by em...
Objective: This study aimed to mask the bitter taste of itopride HCl using the solid dispersion meth...
The present study was designed to evaluate the preparation and quality of ibuprofen and diphenhydram...
Objective: Glibenclamide belongs to the 2nd generation sulfonylurea group as an oral antidiabetic wi...